The efficacy and safety of DW1601 in patients with acute bronchitis: a multi-center, ...

1. Smith MP, Lown M, Singh S, et al. Acute cough due to acute bronchitis in immunocompetent adult outpatients: CHEST expert panel report. Chest 2020;157:1256–1265.
crossref pmid pmc
2. Kinkade S, Long NA. Acute bronchitis. Am Fam Physician 2016;94:560–565.
pmid
3. Gonzales R, Sande MA. Uncomplicated acute bronchitis. Ann Intern Med 2000;133:981–991.
crossref pmid
4. Wenzel RP, Fowler AA 3rd. Clinical practice. Acute bronchitis. N Engl J Med 2006;355:2125–2130.
crossref pmid
5. Malesker MA, Callahan-Lyon P, Ireland B, Irwin RS, CHEST Expert Cough Panel. Pharmacologic and nonpharmacologic treatment for acute cough associated with the common cold: CHEST expert panel report. Chest 2017;152:1021–1037.
crossref pmid pmc
6. Keller JA, McGovern AE, Mazzone SB. Translating cough mechanisms into better cough suppressants. Chest 2017;152:833–841.
crossref pmid
7. Young EC, Smith JA. Quality of life in patients with chronic cough. Ther Adv Respir Dis 2010;4:49–55.
crossref pmid pdf
8. Bagcchi S. Stigma during the COVID-19 pandemic. Lancet Infect Dis 2020;20:782.
crossref pmid pmc
9. Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 2020;395:912–920.
crossref pmid pmc
10. Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2017;6:CD000245.
crossref pmid pmc
11. Albert RH. Diagnosis and treatment of acute bronchitis. Am Fam Physician 2010;82:1345–1350.
pmid
12. Smith SM, Smucny J, Fahey T. Antibiotics for acute bronchitis. JAMA 2014;312:2678–2679.
crossref pmid
13. Hill AT, Gold PM, El Solh AA, et al. Adult outpatients with acute cough due to suspected pneumonia or influenza: CHEST guideline and expert panel report. Chest 2019;155:155–167.
pmid
14. Agbabiaka TB, Guo R, Ernst E. Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis. Phytomedicine 2008;15:378–385.
crossref pmid
15. Timmer A, Gunther J, Motschall E, Rucker G, Antes G, Kern WV. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev 2013;10:CD006323.
crossref pmid
16. Matthys H, Kamin W, Funk P, Heger M. Pelargonium sidoides preparation (EPs 7630) in the treatment of acute bronchitis in adults and children. Phytomedicine 2007;14:Suppl 6. 69–73.
crossref pmid
17. Bao Y, Gao Y, Koch E, Pan X, Jin Y, Cui X. Evaluation of pharmacodynamic activities of EPs® 7630, a special extract from roots of Pelargonium sidoides, in animals models of cough, secretolytic activity and acute bronchitis. Phytomedicine 2015;22:504–509.
crossref pmid pmc
18. Kamin W, Maydannik V, Malek FA, Kieser M. Efficacy and tolerability of Eps 7630 in children and adolescents with acute bronchitis: a randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots. Int J Clin Pharmacol Ther 2010;48:184–191.
crossref pmid
19. Riley DS, Lizogub VG, Heger M, Funk P, Mueller H, Lehmacher W. Treatment with EPs 7630, a Pelargonium sidoides root extract, is effective and safe in patients with the common cold: results from a randomized, double blind, placebo-controlled clinical trial. Integr Med (Encinitas) 2019;18:42–51. 20. Matthys H, Kamin W. Positioning of the Bronchitis Severity Score (BSS) for standardised use in clinical studies. Curr Med Res Opin 2013;29:1383–1390.
crossref
21. Kardos P, Lehrl S, Kamin W, Matthys H. Assessment of the effect of pharmacotherapy in common cold/acute bronchitis: the Bronchitis Severity Scale (BSS). Pneumologie 2014;68:542–546.
crossref pmid
22. Visca D, Beghe B, Fabbri LM, Papi A, Spanevello A. Management of chronic refractory cough in adults. Eur J Intern Med 2020;81:15–21.
crossref pmid pmc
23. Morice AH, Millqvist E, Bieksiene K, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 2020;55:1901136.
crossref pmid pmc
24. Silveira D, Prieto-Garcia JM, Boylan F, et al. COVID-19: is there evidence for the use of herbal medicines as adjuvant symptomatic therapy? Front Pharmacol 2020;11:581840.
crossref pmid pmc
25. Papies J, Emanuel J, Heinemann N, et al. Antiviral and immunomodulatory effects of Pelargonium sidoides DC. Root extract EPs® 7630 in SARS-CoV-2-infected human lung cells. Front Pharmacol 2021;12:757666.
crossref pmid pmc
26. Keck T, Strobl A, Weinhaeusel A, Funk P, Michaelis M. Pelargonium extract EPs 7630 in the treatment of human corona virus-associated acute respiratory tract infections: a secondary subgroup-analysis of an open-label, uncontrolled clinical trial. Front Pharmacol 2021;12:666546.
crossref pmid pmc
27. Beard JR, Officer A, de Carvalho IA, et al. The World report on ageing and health: a policy framework for healthy ageing. Lancet 2016;387:2145–2154.
crossref pmid
28. Beard JR, Officer AM, Cassels AK. The world report on ageing and health. Gerontologist 2016;56:Suppl 2. S163–S166.
crossref pmid

留言 (0)

沒有登入
gif